Report cover image

Global Infectious Substance Packaging Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 104 Pages
SKU # APRC20550587

Description

Summary

According to APO Research, The global Infectious Substance Packaging market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Infectious Substance Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Infectious Substance Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Infectious Substance Packaging is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Infectious Substance Packaging include Air Sea Containers, CIBESMED Ltd, ALEX BREUER GMBH, E3 Cortex, Berlin Packaging LLC, CFT Canada, ICC, Therapak™ and Serpac, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Substance Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Substance Packaging.
The Infectious Substance Packaging market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Substance Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Infectious Substance Packaging Segment by Company

Air Sea Containers
CIBESMED Ltd
ALEX BREUER GMBH
E3 Cortex
Berlin Packaging LLC
CFT Canada
ICC
Therapak™
Serpac
Friobox
Infectious Substance Packaging Segment by Type

UN2814
UN2900
UN3373
Others
Infectious Substance Packaging Segment by Application

Healthcare and Medical Laboratories
Pharmaceutical Industry
Veterinary Medicine
Hazardous Waste Management
Infectious Substance Packaging Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Substance Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infectious Substance Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Substance Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Substance Packaging manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Infectious Substance Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

104 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Infectious Substance Packaging Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Infectious Substance Packaging Sales Estimates and Forecasts (2020-2031)
1.3 Infectious Substance Packaging Market by Type
1.3.1 UN2814
1.3.2 UN2900
1.3.3 UN3373
1.3.4 Others
1.4 Global Infectious Substance Packaging Market Size by Type
1.4.1 Global Infectious Substance Packaging Market Size Overview by Type (2020-2031)
1.4.2 Global Infectious Substance Packaging Historic Market Size Review by Type (2020-2025)
1.4.3 Global Infectious Substance Packaging Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Infectious Substance Packaging Sales Breakdown by Type (2020-2025)
1.5.2 Europe Infectious Substance Packaging Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Infectious Substance Packaging Sales Breakdown by Type (2020-2025)
1.5.4 South America Infectious Substance Packaging Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Infectious Substance Packaging Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Infectious Substance Packaging Industry Trends
2.2 Infectious Substance Packaging Industry Drivers
2.3 Infectious Substance Packaging Industry Opportunities and Challenges
2.4 Infectious Substance Packaging Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Infectious Substance Packaging Revenue (2020-2025)
3.2 Global Top Players by Infectious Substance Packaging Sales (2020-2025)
3.3 Global Top Players by Infectious Substance Packaging Price (2020-2025)
3.4 Global Infectious Substance Packaging Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Infectious Substance Packaging Major Company Production Sites & Headquarters
3.6 Global Infectious Substance Packaging Company, Product Type & Application
3.7 Global Infectious Substance Packaging Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Infectious Substance Packaging Market CR5 and HHI
3.8.2 Global Top 5 and 10 Infectious Substance Packaging Players Market Share by Revenue in 2024
3.8.3 2023 Infectious Substance Packaging Tier 1, Tier 2, and Tier 3
4 Infectious Substance Packaging Regional Status and Outlook
4.1 Global Infectious Substance Packaging Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Infectious Substance Packaging Historic Market Size by Region
4.2.1 Global Infectious Substance Packaging Sales in Volume by Region (2020-2025)
4.2.2 Global Infectious Substance Packaging Sales in Value by Region (2020-2025)
4.2.3 Global Infectious Substance Packaging Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Infectious Substance Packaging Forecasted Market Size by Region
4.3.1 Global Infectious Substance Packaging Sales in Volume by Region (2026-2031)
4.3.2 Global Infectious Substance Packaging Sales in Value by Region (2026-2031)
4.3.3 Global Infectious Substance Packaging Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Infectious Substance Packaging by Application
5.1 Infectious Substance Packaging Market by Application
5.1.1 Healthcare and Medical Laboratories
5.1.2 Pharmaceutical Industry
5.1.3 Veterinary Medicine
5.1.4 Hazardous Waste Management
5.2 Global Infectious Substance Packaging Market Size by Application
5.2.1 Global Infectious Substance Packaging Market Size Overview by Application (2020-2031)
5.2.2 Global Infectious Substance Packaging Historic Market Size Review by Application (2020-2025)
5.2.3 Global Infectious Substance Packaging Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Infectious Substance Packaging Sales Breakdown by Application (2020-2025)
5.3.2 Europe Infectious Substance Packaging Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Infectious Substance Packaging Sales Breakdown by Application (2020-2025)
5.3.4 South America Infectious Substance Packaging Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Infectious Substance Packaging Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Air Sea Containers
6.1.1 Air Sea Containers Comapny Information
6.1.2 Air Sea Containers Business Overview
6.1.3 Air Sea Containers Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Air Sea Containers Infectious Substance Packaging Product Portfolio
6.1.5 Air Sea Containers Recent Developments
6.2 CIBESMED Ltd
6.2.1 CIBESMED Ltd Comapny Information
6.2.2 CIBESMED Ltd Business Overview
6.2.3 CIBESMED Ltd Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CIBESMED Ltd Infectious Substance Packaging Product Portfolio
6.2.5 CIBESMED Ltd Recent Developments
6.3 ALEX BREUER GMBH
6.3.1 ALEX BREUER GMBH Comapny Information
6.3.2 ALEX BREUER GMBH Business Overview
6.3.3 ALEX BREUER GMBH Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ALEX BREUER GMBH Infectious Substance Packaging Product Portfolio
6.3.5 ALEX BREUER GMBH Recent Developments
6.4 E3 Cortex
6.4.1 E3 Cortex Comapny Information
6.4.2 E3 Cortex Business Overview
6.4.3 E3 Cortex Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.4.4 E3 Cortex Infectious Substance Packaging Product Portfolio
6.4.5 E3 Cortex Recent Developments
6.5 Berlin Packaging LLC
6.5.1 Berlin Packaging LLC Comapny Information
6.5.2 Berlin Packaging LLC Business Overview
6.5.3 Berlin Packaging LLC Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Berlin Packaging LLC Infectious Substance Packaging Product Portfolio
6.5.5 Berlin Packaging LLC Recent Developments
6.6 CFT Canada
6.6.1 CFT Canada Comapny Information
6.6.2 CFT Canada Business Overview
6.6.3 CFT Canada Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CFT Canada Infectious Substance Packaging Product Portfolio
6.6.5 CFT Canada Recent Developments
6.7 ICC
6.7.1 ICC Comapny Information
6.7.2 ICC Business Overview
6.7.3 ICC Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ICC Infectious Substance Packaging Product Portfolio
6.7.5 ICC Recent Developments
6.8 Therapak™
6.8.1 Therapak™ Comapny Information
6.8.2 Therapak™ Business Overview
6.8.3 Therapak™ Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Therapak™ Infectious Substance Packaging Product Portfolio
6.8.5 Therapak™ Recent Developments
6.9 Serpac
6.9.1 Serpac Comapny Information
6.9.2 Serpac Business Overview
6.9.3 Serpac Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Serpac Infectious Substance Packaging Product Portfolio
6.9.5 Serpac Recent Developments
6.10 Friobox
6.10.1 Friobox Comapny Information
6.10.2 Friobox Business Overview
6.10.3 Friobox Infectious Substance Packaging Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Friobox Infectious Substance Packaging Product Portfolio
6.10.5 Friobox Recent Developments
7 North America by Country
7.1 North America Infectious Substance Packaging Sales by Country
7.1.1 North America Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Infectious Substance Packaging Sales by Country (2020-2025)
7.1.3 North America Infectious Substance Packaging Sales Forecast by Country (2026-2031)
7.2 North America Infectious Substance Packaging Market Size by Country
7.2.1 North America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Infectious Substance Packaging Market Size by Country (2020-2025)
7.2.3 North America Infectious Substance Packaging Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Infectious Substance Packaging Sales by Country
8.1.1 Europe Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Infectious Substance Packaging Sales by Country (2020-2025)
8.1.3 Europe Infectious Substance Packaging Sales Forecast by Country (2026-2031)
8.2 Europe Infectious Substance Packaging Market Size by Country
8.2.1 Europe Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Infectious Substance Packaging Market Size by Country (2020-2025)
8.2.3 Europe Infectious Substance Packaging Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Infectious Substance Packaging Sales by Country
9.1.1 Asia-Pacific Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Infectious Substance Packaging Sales by Country (2020-2025)
9.1.3 Asia-Pacific Infectious Substance Packaging Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Infectious Substance Packaging Market Size by Country
9.2.1 Asia-Pacific Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Infectious Substance Packaging Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Infectious Substance Packaging Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Infectious Substance Packaging Sales by Country
10.1.1 South America Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Infectious Substance Packaging Sales by Country (2020-2025)
10.1.3 South America Infectious Substance Packaging Sales Forecast by Country (2026-2031)
10.2 South America Infectious Substance Packaging Market Size by Country
10.2.1 South America Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Infectious Substance Packaging Market Size by Country (2020-2025)
10.2.3 South America Infectious Substance Packaging Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Infectious Substance Packaging Sales by Country
11.1.1 Middle East and Africa Infectious Substance Packaging Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Infectious Substance Packaging Sales by Country (2020-2025)
11.1.3 Middle East and Africa Infectious Substance Packaging Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Infectious Substance Packaging Market Size by Country
11.2.1 Middle East and Africa Infectious Substance Packaging Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Infectious Substance Packaging Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Infectious Substance Packaging Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Infectious Substance Packaging Value Chain Analysis
12.1.1 Infectious Substance Packaging Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Infectious Substance Packaging Production Mode & Process
12.2 Infectious Substance Packaging Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Infectious Substance Packaging Distributors
12.2.3 Infectious Substance Packaging Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.